OBJECTIVE

Evaluation of the effectiveness of flavonoids in the postoperative management of patients with hemorrhoids.

MATERIAL AND METHODS

A single-center randomized controlled clinical trial was conducted. Patients with stage III and IV hemorrhoids aged over 18 years who patients who underwent hemorrhoidectomy were included.

The patients were divided into 2 groups — main and control. Patients in the main group were recommended to use a purified micronized flavonoid fraction — 65 patients. In the control group (70 patients), the use of this group of drugs was not expected.

The observation period was 60 days. After discharge from the hospital, 5 patient visits were scheduled: on the 3rd, 7th, 21st, 40th and 60th day after surgery. Patients independently assessed the intensity of symptoms — pain, tenesmus, itching and bleeding.

The randomization procedure was carried out using the method of simple randomization using envelopes.

RESULTS

135 patients were randomized. There were no patients who dropped out of the study. The number of participants whose data were included in the analysis was 65 patients in the main group and 70 patients in the control group.

Assessment of symptoms in the first 3 days of the postoperative period did not show a significant difference in the condition of the patients. Over time, we found significant changes in the dynamics of complaints between groups. After 7, 21, 40 and 60 days, a statistically significant lower severity of pain, bleeding and tenesmus was revealed among patients in the main group compared to the control group. This trend was not detected in the assessment of itching. There were no undesirable effects.

CONCLUSION

The use of purified micronized flavonoid fraction in the postoperative management of patients with hemorrhoids can significantly reduce the degree and duration of pain, bleeding and tenesmus.